SCOTT JOHN K JR. reported 1 transaction at NAVIDEA BIOPHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/5/2023ACC: 0001415889-23-015898
10% Owner
Since Sep 2018
+59.62K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
64.29K acquired · 4.67K disposed
Non-Derivative Transactions1
Series G Redeemable Preferred Stock
Direct
Shares
−2.27K
Price / share
—
Trade value
—
% of position
New position
11/27/2023
2.27K→0.00
Total
Net shares
−2.27K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series G Redeemable Preferred Stock Direct | 11/27/2023 | J · J | −2.27K | — | — | New position | 2.27K | 0.00 |
| Total | −2.27K | $0.00 | ||||||
Derivative Transactions2
Series I Convertible Preferred Stock
Direct
Converts to
Common Stock
15M shares
Shares
−2.40K
Strike price
0.16
Held after
0.00
Exercisable
—
11/27/2023
Series J Convertible Preffered Stock
Direct
Converts to
Common Stock
61.82M shares
Shares
+64.29K
Strike price
0.104
Held after
64.29K
Exercisable
—
11/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series I Convertible Preferred Stock Direct | Common Stock15M shares | 11/27/2023 | J · J | −2.40K | 0.16 | — | 0.00 |
| Series J Convertible Preffered Stock Direct | Common Stock61.82M shares | 11/27/2023 | J · J | +64.29K | 0.104 | — | 64.29K |